Clinical Trials on Recurrent or Metastatic Breast Cancer
Total 19246 results
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...RecruitingLocally Advanced, Recurrent or Metastatic MalignanciesChina
-
MediLink Therapeutics (Suzhou) Co., Ltd.RecruitingBreast Cancer | NSCLC | HNSCC | Locally Advanced or Metastatic Solid TumorsChina
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Endometrial Carcinoma | Male Breast Cancer | Recurrent Small Cell Lung Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Gastric Cancer | Recurrent Non-small Cell Lung CancerUnited States
-
University of ZurichUnknownBreast Cancer | Metastatic Neoplasm | ERBB2Switzerland
-
BeiGeneRecruitingBreast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Hormone Receptor Positive Malignant Neoplasm of Breast | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerChina
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Advanced Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
Washington University School of MedicineUnited States Department of Defense; Aclaris Therapeutics, Inc.Not yet recruitingHormone Receptor Positive HER-2 Negative Metastatic Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | HER2/Neu Negative | Recurrent Inflammatory Breast Carcinoma | Stage IV Inflammatory Breast CarcinomaUnited States
-
CellabMEDYooyoung Pharmaceutical Co., Ltd.CompletedColorectal Cancer Metastatic | Colorectal Cancer RecurrentKorea, Republic of
-
Pravin T.P KaumayaNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoma | EGFR OverexpressionUnited States
-
Immatics Biotechnologies GmbHRecruitingCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerGermany
-
AkesoAkesobio Australia Pty LtdCompletedMetastatic Cervical Cancer | Recurrent Cervical CancerUnited States, Australia, New Zealand
-
BiocadUnknownCervical Cancer | Cervical Cancer Recurrent | Cervical Cancer MetastaticRussian Federation
-
UNICANCERSeagen Inc.RecruitingHER2-positive Metastatic Breast Cancer | Leptomeningeal Disease | Leptomeningeal MetastasisFrance
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage...United States
-
Outcomes4MeMassachusetts General HospitalUnknownBreast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Metastatic Breast CarcinomaUnited States
-
Artios Pharma LtdActive, not recruitingBreast Cancer | Metastatic Cancer | Advanced CancerUnited States, United Kingdom
-
UNICANCERARCAGY/ GINECO GROUP; SOLTI Breast Cancer Research GroupActive, not recruitingER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer | a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI StatusFrance
-
Sapience TherapeuticsRecruitingHepatocellular Carcinoma | Pancreatic Cancer | Ovarian Cancer | Cholangiocarcinoma | Triple Negative Breast Cancer | Metastatic Melanoma | Colon Cancer | Synovial Sarcoma | Breast Cancer Metastatic | Metastatic Colon Cancer | Melanoma Stage IV | Melanoma Recurrent | TNBC - Triple-Negative Breast Cancer | NSCLC, Metastatic and other conditionsUnited States
-
Yonsei UniversityUnknownInoperable or Recurrent or Metastatic Esophageal Squamous CarcinomaKorea, Republic of
-
Sunnybrook Health Sciences CentreAFP Innovation FundRecruitingBreast Cancer | Breast Neoplasms | Metastatic Breast Cancer | Cancer, BreastCanada
-
Hoffmann-La RocheCompletedBreast Cancer, Metastatic Breast CancerSerbia
-
Aadi Bioscience, Inc.Active, not recruitingMalignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic NeoplasmUnited States, Korea, Republic of, Puerto Rico
-
QuantumLeap Healthcare CollaborativeByondis B.V.WithdrawnOvarian Cancer | Metastatic Cancer | Metastatic Breast Cancer | Bladder Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Gastroesophageal Adenocarcinoma | Ovarian Carcinoma | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoid Tumor | HER2-positive Metastatic Breast... and other conditionsUnited States
-
Tianhong LiNational Cancer Institute (NCI); LabyRx Immunologic TherapeuticsRecruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Adenocarcinoma | Advanced Adenocarcinoma | Recurrent AdenocarcinomaUnited States
-
British Columbia Cancer AgencyBC Cancer FoundationRecruitingAdvanced Cancers | Metastatic Cancers | Cancers That Cannot be Treated With Curative IntentCanada
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | ER+ Breast Cancer | Metastatic Breast Carcinoma | HER2+ Breast Cancer | Oligometastatic Breast CarcinomaUnited States
-
University of South AlabamaExelixisTerminatedCervical Cancer | Metastatic Cervical Cancer | Recurrent Cervical Cancer | Persistent Cervical CancerUnited States
-
Alpha Tau Medical LTD.TerminatedMetastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Distant Metastases.PathologyRussian Federation
-
National Center of Oncology, ArmeniaBRIU GmbHCompletedAdvanced Breast Cancer | Metastatic Breast CancerArmenia
-
SanofiCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast CancerUnited States
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerJapan
-
National Taiwan University HospitalRecruitingMetastatic Breast Cancer | Premenopausal Breast Cancer | ER Positive Breast CancerTaiwan
-
MedSIRMacroGenics; Seagen Inc.WithdrawnAdvanced Breast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer
-
Centre Leon BerardGlaxoSmithKlineRecruitingRecurrent Cancer | Second Cancer | Primary CancerFrance
-
Immatics Biotechnologies GmbHBristol-Myers SquibbRecruitingCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerGermany
-
University of PennsylvaniaActive, not recruitingBreast Neoplasm | Metastatic Breast Cancer | Rb+ Breast CancerUnited States
-
M.D. Anderson Cancer CenterTempus AIActive, not recruitingMetastatic Malignant Neoplasm | Recurrent Malignant NeoplasmUnited States
-
Olema Pharmaceuticals, Inc.NovartisRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast CancerUnited States, Australia
-
Stanford UniversityTerminatedBreast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer Metastatic Breast CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Prostate Adenocarcinoma | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Male Breast CarcinomaUnited States, Canada, Switzerland
-
Thomas Jefferson UniversityAstraZenecaActive, not recruitingRecurrent Breast Carcinoma | Metastatic Malignant Neoplasm in the Chest WallUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Esophageal Carcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | Stage IV Esophageal Cancer AJCC v7 | Metastatic Esophageal Squamous Cell Carcinoma | Metastatic Esophageal Adenocarcinoma | Recurrent Gastroesophageal Junction Adenocarcinoma | Recurrent Esophageal Adenocarcinoma and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingHead and Neck Squamous Cell Cancer | Recurrent Head and Neck Squamous Cell Cancer | Metastatic Head and Neck Squamous Cell CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingFatigue | Metastatic CancersUnited States
-
University Hospital TuebingenRecruitingAdvanced/Metastatic Breast Cancer | Breast Cancer (Early Breast Cancer)Germany
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Metastatic Breast AdenocarcinomaUnited States